Healthequity (HQY) EBIT (2013 - 2026)

Healthequity's EBIT history runs 14 years deep, the most recent figure standing at $103.0 million for Q2 2026.

• In Q2 2026, EBIT rose 23.92% year-over-year to $103.0 million; the TTM figure through Apr 2026 stood at $342.3 million (up 67.99% YoY), while the FY2026 annual figure was $322.5 million, up 98.64% from the prior year.
• EBIT was $103.0 million for Q2 2026 at Healthequity, up from $71.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $103.0 million in Q2 2026 to a low of -$27.2 million in Q1 2022.
• Historically, EBIT has averaged $38.2 million across 5 years, with a median of $34.9 million in 2023.
• Biggest YoY gain for EBIT was 1614.21% in 2022; the steepest drop was 1617.08% in 2022.
• A 5-year view of EBIT shows it stood at $5.5 million in 2022, then surged by 457.4% to $30.9 million in 2023, then plunged by 36.47% to $19.6 million in 2024, then soared by 300.99% to $78.7 million in 2025, then soared by 30.83% to $103.0 million in 2026.
• The last three EBIT figures came in at $103.0 million (Q2 2026), $71.1 million (Q1 2026), and $78.7 million (Q4 2025), per Business Quant data.